161
Views
38
CrossRef citations to date
0
Altmetric
Drug Evaluation

131I-chTNT-1/B mAb: tumour necrosis therapy for malignant astrocytic glioma

, , &
Pages 539-545 | Published online: 13 Apr 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Alia Hdeib & Andrew E Sloan. (2011) Convection-enhanced delivery of 131I-chTNT-1/B mAB for treatment of high-grade adult gliomas. Expert Opinion on Biological Therapy 11:6, pages 799-806.
Read now
Waldemar Debinski & Stephen B Tatter. (2009) Convection-enhanced delivery for the treatment of brain tumors. Expert Review of Neurotherapeutics 9:10, pages 1519-1527.
Read now
Jill M Stukel & Michael R Caplan. (2009) Targeted drug delivery for treatment and imaging of glioblastoma multiforme. Expert Opinion on Drug Delivery 6:7, pages 705-718.
Read now
Sherise D Ferguson, Kimberly Foster & Bakhtiar Yamini. (2007) Convection-enhanced delivery for treatment of brain tumors. Expert Review of Anticancer Therapy 7:sup1, pages S79-S85.
Read now
David E Gerber & John Laterra. (2007) Emerging monoclonal antibody therapies for malignant gliomas. Expert Opinion on Investigational Drugs 16:4, pages 477-494.
Read now
Herbert B Newton. (2006) Advances in strategies to improve drug delivery to brain tumors. Expert Review of Neurotherapeutics 6:10, pages 1495-1509.
Read now

Articles from other publishers (32)

Catarina I.G. Pinto, Joana F. Guerreiro, Francisco Silva, Filipa Mendes & António Paulo. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 667 705 .
C.S. Bal & Geetanjali Arora. 2023. New Insights Into Glioblastoma. New Insights Into Glioblastoma 613 630 .
Saikat Ghosh, Pie Huda, Nicholas L. Fletcher, Christopher B. Howard, Bradley Walsh, Douglas Campbell, Mark B. Pinkham & Kristofer J. Thurecht. (2022) Antibody-Based Formats to Target Glioblastoma: Overcoming Barriers to Protein Drug Delivery. Molecular Pharmaceutics 19:5, pages 1233-1247.
Crossref
Maria Cristina Oliveira & João D. G. Correia. (2022) Clinical application of radioiodinated antibodies: where are we?. Clinical and Translational Imaging 10:2, pages 123-162.
Crossref
Rodolfo Núñez. 2022. Radiopharmaceuticals in the Management of Leptomeningeal Metastasis. Radiopharmaceuticals in the Management of Leptomeningeal Metastasis 21 69 .
S. Arab & F. Hasannejad. (2021) An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach. Clinical and Translational Oncology 24:5, pages 742-756.
Crossref
Fulvio Zaccagna, James T. Grist, Natale Quartuccio, Frank Riemer, Francesco Fraioli, Corradina Caracò, Richard Halsey, Yazeed Aldalilah, Charles H. Cunningham, Tarik F. Massoud, Luigi Aloj & Ferdia A. Gallagher. (2021) Imaging and treatment of brain tumors through molecular targeting: Recent clinical advances. European Journal of Radiology 142, pages 109842.
Crossref
Ming Zhao, Xiangping Fu, Zhiwen Zhang, Anmin Li, Xiaopeng Wang & Xuexiu Li. (2021) Intracranial 131I-chTNT Brachytherapy in Patients with Deep-Seated Glioma: A Single-center Experience with 10-Year Follow-up from China. Nuklearmedizin - NuclearMedicine 60:04, pages 283-288.
Crossref
Sodam Kim, Sang-Gu Yim, Ajeesh Chandrasekharan, Keum-Yong Seong, Tae Wook Lee, Byeongyeon Kim, Keunyoung Kim, Sungyoung Choi & Seung Yun Yang. (2020) On-site fabrication of injectable 131I-labeled microgels for local radiotherapy. Journal of Controlled Release 322, pages 337-345.
Crossref
Ali Gholamrezanezhad, Hossein Shooli, Narges Jokar, Reza Nemati & Majid Assadi. (2019) Radioimmunotherapy (RIT) in Brain Tumors. Nuclear Medicine and Molecular Imaging 53:6, pages 374-381.
Crossref
Puttemans, Lahoutte, D’Huyvetter & Devoogdt. (2019) Beyond the Barrier: Targeted Radionuclide Therapy in Brain Tumors and Metastases. Pharmaceutics 11:8, pages 376.
Crossref
Clément Bailly, Aurelien Vidal, Coralie Bonnemaire, Françoise Kraeber-Bodéré, Michel Chérel, Amandine Pallardy, Caroline Rousseau, Emmanuel Garcion, Franck Lacoeuille, François Hindré, Samuel Valable, Myriam Bernaudin, Caroline Bodet-Milin & Mickaël Bourgeois. (2019) Potential for Nuclear Medicine Therapy for Glioblastoma Treatment. Frontiers in Pharmacology 10.
Crossref
Hans-Jürgen Reulen, Eric Suero Molina, Reinhard Zeidler, Franz Josef Gildehaus, Guido Böning, Astrid Gosewisch & Walter Stummer. (2019) Intracavitary radioimmunotherapy of high-grade gliomas: present status and future developments. Acta Neurochirurgica 161:6, pages 1109-1124.
Crossref
Dongjian Zhang, Meng Gao, Qiaomei Jin, Yicheng Ni & Jian Zhang. (2019) Updated developments on molecular imaging and therapeutic strategies directed against necrosis. Acta Pharmaceutica Sinica B 9:3, pages 455-468.
Crossref
Eszter Boros & Jason P. Holland. (2018) Chemical aspects of metal ion chelation in the synthesis and application antibody‐based radiotracers. Journal of Labelled Compounds and Radiopharmaceuticals 61:9, pages 652-671.
Crossref
Cong Wang, Qiaomei Jin, Shengwei Yang, Dongjian Zhang, Qin Wang, Jindian Li, Shaoli Song, Ziping Sun, Yicheng Ni, Jian Zhang & Zhiqi Yin. (2015) Synthesis and Evaluation of 131 I-Skyrin as a Necrosis Avid Agent for Potential Targeted Radionuclide Therapy of Solid Tumors . Molecular Pharmaceutics 13:1, pages 180-189.
Crossref
Joseph Gerard Jurcic, Jeffrey Y.C. Wong, Susan J. Knox, Daniel R. Wahl, Todd L. Rosenblat & Ruby F. Meredith. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology 399 418.e14 .
François Autelitano, Denis Loyaux, Sébastien Roudières, Catherine Déon, Frédérique Guette, Philippe Fabre, Qinggong Ping, Su Wang, Romane Auvergne, Vasudeo Badarinarayana, Michael Smith, Jean-Claude Guillemot, Steven A. Goldman, Sridaran Natesan, Pascual Ferrara & Paul August. (2014) Identification of Novel Tumor-Associated Cell Surface Sialoglycoproteins in Human Glioblastoma Tumors Using Quantitative Proteomics. PLoS ONE 9:10, pages e110316.
Crossref
M. H. Parseghian, E. Mechetner, M. S. Osidak & S. P. Domogatskii. (2014) Application of monoclonal antibodies for the diagnostic and therapeutic targeting of human tumors with a necrotic component. Russian Journal of General Chemistry 84:2, pages 345-356.
Crossref
Betty M. Tyler, Gustavo Pradilla, Uri Hadelsberg, Hansen Bow, Ian Suk & Henry Brem. 2014. Focal Controlled Drug Delivery. Focal Controlled Drug Delivery 169 194 .
Silke Gillessen, Ulrike S. Gnad-Vogt, Elisa Gallerani, Joachim Beck, Cristiana Sessa, Aurelius Omlin, Maria R. Mattiacci, Bernd Liedert, Daniel Kramer, Julien Laurent, Daniel E. Speiser & Roger Stupp. (2013) A phase I dose-escalation study of the immunocytokine EMD 521873 (Selectikine) in patients with advanced solid tumours. European Journal of Cancer 49:1, pages 35-44.
Crossref
Dana Litvak-Greenfeld & Itai Benhar. (2012) Risks and untoward toxicities of antibody-based immunoconjugates. Advanced Drug Delivery Reviews 64:15, pages 1782-1799.
Crossref
Alia Hdeib & Andrew Sloan. (2012) Targeted radioimmunotherapy: the role of 131 I-chTNT-1/B mAb (Cotara ® ) for treatment of high-grade gliomas . Future Oncology 8:6, pages 659-669.
Crossref
Ruby F. Meredith, Jeffrey Y.C. Wong & Susan J. Knox. 2012. Clinical Radiation Oncology. Clinical Radiation Oncology e22-1 e22-46 .
Robert M Sharkey & David M Goldenberg. (2011) Cancer radioimmunotherapy. Immunotherapy 3:3, pages 349-370.
Crossref
Leopold Arko, Igor Katsyv, Grace E. Park, William Patrick Luan & John K. Park. (2010) Experimental approaches for the treatment of malignant gliomas. Pharmacology & Therapeutics 128:1, pages 1-36.
Crossref
Jill M. Stukel, Ronald C. Li, Heather D. Maynard & Michael R. Caplan. (2009) Two-Step Synthesis of Multivalent Cancer-Targeting Constructs. Biomacromolecules 11:1, pages 160-167.
Crossref
Christina A. Kousparou & Agamemnon A. Epenetos. 2009. Recombinant Antibodies for Immunotherapy. Recombinant Antibodies for Immunotherapy 174 189 .
V. P. Baklaushev, K. A. Pavlov & V. P. Chekhonin. (2009) Monoclonal antibodies in diagnostics of high-grade gliomas. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 3:2, pages 105-115.
Crossref
Hui-qi LU. (2008) Panning and identification of humanized antinuclear antibody Fab fragment. Academic Journal of Second Military Medical University 28:1, pages 87-91.
Crossref
C. Andrew Boswell & Martin W. Brechbiel. (2007) Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view. Nuclear Medicine and Biology 34:7, pages 757-778.
Crossref
Christian Menzel & Stefan Dübel. 2007. Handbook of Therapeutic Antibodies. Handbook of Therapeutic Antibodies 1131 1147 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.